- Continue Shopping
- Your Cart is Empty
Join Us for a new Astroskin LIVE Event!
Join us for our new Astroskin LIVE Demo on September 21, 2022, at 11:00 a.m. EDT. Our team will perform a complete demo of the industry-leading Astroskin Vital Signs Monitoring Platform.
Our LIVE Demo events are good opportunities to meet the Hexoskin team and learn more about everything related to our solutions for remote health monitoring.
Whether you are new to Astroskin or need a refresh on the Astroskin platform, our Astroskin Live Demo will provide a deep look at the Astroskin features, including new functionalities.
Hexoskin Receives 2022 International Space Station Research Innovation Award for Human Health in Space from American Astronautical Society
Washington, D.C. - July 28th, 2022
The American Astronautical Society has awarded today the 2022 International Space Station Research Innovation Award for Human Health in Space to Hexoskin (Carré Technologies Inc.) for demonstrating a comprehensive physiology monitoring system for use in research and in situ crew care.
The Astroskin Bio-Monitor System was launched with SpaceX mission CRS-16 in December 2018 and was commissioned by Canadian astronaut David Saint-Jacques in January 2019. It is currently used in two clinical trials in microgravity to improve our understanding of cardiovascular health in space and physiological models of aging. These studies will help support human health during long-term space missions beyond Earth's orbit: to the Moon, Mars, and beyond.
"This award celebrates 10 years of collaboration between Hexoskin and space agencies, and a technology that has a real impact on medical research in space and in our communities" said Pierre-Alexandre Fournier, CEO and co-founder of Hexoskin.
The Hexoskin space medicine team supports the operations of the Astroskin Bio-Monitor in space with the collaboration of the Canadian Space Agency, NASA, and other space agencies and subcontractors.
About Astroskin
Astroskin is the most advanced ambulatory vital signs monitoring platform for medical research in the world. Developed to qualify for space research, it can now benefit the most innovative research in Space and on Earth.
Astroskin offers state-of-the-art continuous real-time monitoring for 48 hours of blood pressure, pulse oximetry, 3-lead ECG, respiration, skin temperature, and activity.
The Astroskin garments are now available in a wide range of sizes for men & women. A large number of research organizations already use the Astroskin vital signs monitoring platform to collect data to answer their research questions.
About the ISS R&D Conference
The International Space Station Research and Development Conference (ISSRDC) brings together leaders from the commercial sector, U.S. government agencies, and academic communities to foster innovation and discovery onboard the International Space Station (ISS).
The conference is hosted by the Center for the Advancement of Science in Space, Inc., manager of the ISS National Laboratory; NASA; and the American Astronautical Society (AAS). ISSRDC showcases how the space station continues to provide a valuable platform for research and technology development that benefits humanity and enables a robust and sustainable market in low Earth orbit. Additionally, the ISSRDC marketplace expo allows companies to showcase how they are advancing opportunities in low Earth orbit and provides a venue to meet with researchers, stakeholders, and policymakers.
About the American Astronautical Society
The American Astronautical Society (AAS), established in 1899, is a major international organization of professional astronomers, astronomy educators, and amateur astronomers. Its membership of approximately 8,000 also includes physicists, geologists, engineers, and others whose interests lie within the broad spectrum of subjects now comprising the astronautical sciences.
The mission of the AAS is to enhance and share humanity’s scientific understanding of the universe as a diverse and inclusive astronautical community, which it achieves through publishing, meetings, science advocacy, education and outreach, and training and professional development.
Axiom-1 Mission Ready to Blast Off!
Canadian Private Astronaut Mark Pathy and his crew members have been busy training at NASA Johnson Space Center ahead of the launch. The Axiom-1 mission was recently cleared by NASA and is set to blast off from NASA’s Kennedy Space Center in Florida in April. The mission is set to launch today on April 8, 2022.
You can watch the Launch Live here: https://youtu.be/5nLk_Vqp7nw
Ax-1 is the first mission involving an all-private crew of astronauts to reach the International Space Station. The mission will last 10 days with at least eight days are expected to be spent inside the ISS.
Mark Pathy, Axiom Space private Astronaut, will wear the Astroskin while staying on the ISS. He will conduct several research experiments including research on the effects of microgravity, chronic pain, and sleep disturbances. Mark will be joined on Ax-1 by fellow crew members Eytan Stibbe from Israel, Larry Connor, and Michael Lopez-Alegria from the United States.
A New Prospect for Astroskin and the Advancement of Space Research
Initially entirely funded by national space programs, space exploration is getting momentum with several private companies and individuals targeting Space as the next frontier. Hexoskin has collaborated with the Canadian Space Agency since 2012 on space projects, including the Astroskin (Bio Monitor).
Astroskin seamlessly integrates several sensors in one portable smart clothing to report continuously the vital signs remotely. Integrating a precise 3-lead ECG, and Body Inductance Plethysmography (RIP) sensors, Astroskin allows the ambulatory monitoring of the cardiac and lung function, previously only possible with bulky equipment previously available in laboratories. The Astroskin smart clothing also integrates a portable pulse oximeter for continuous blood oxygen and blood pressure monitoring, a skin temperature sensor, and a 3-axis activity sensor for activity and sleep monitoring.
The comfort and convenience of a smart textile explain why Astroskin is currently the health monitoring tool of choice for the ISS participating countries to conduct health research in microgravity and remotely monitor the vital signs of astronauts. More recently, we announced the upcoming mission of Astronaut Kellie Gerardi, set to conduct research with Astroskin on board a Virgin Galactic Flight. Since Astroskin is operational on board the ISS, it opens new opportunities for private astronauts and space companies to use Astroskin for their training and during spaceflight.
We are thrilled to see new missions such as the Ax-1 mission adding Astroskin to their toolkit to conduct meaningful research in Space and contribute like Mark Pathy to the advancement of science with important potential applications on earth and for future space exploration missions.
Join us on March 30th for a New Astroskin Live Event!
The Astroskin Vital Signs Monitoring Platform is an advanced smart clothing used in Space and on Earth for cutting-edge research and projects. Join us live on March 30th at 11:00 am EDT, and meet our speakers to learn more about current and future projects with Astroskin.
Astroskin set to be used in Space by Private Astronaut Mark Pathy
Astroskin will soon be getting another ride to Space, thanks to Canadian Private Astronaut Mark Pathy and the first-ever private mission to the ISS, Ax-1, organized by Axiom Space. The Ax-1 space mission is set to send a crew of four private astronauts to the International Space Station (ISS) on board a SpaceX Crew Dragon. Set to launch in April 2022, Ax-1 is a 10-day mission where at least eight days will be spent inside the ISS to conduct several research experiments including research on the effects of microgravity, chronic pain, and sleep disturbances. Mark will be joined on Ax1 by fellow crew members Eytan Stibbe from Israel, Larry Connor, and Michael Lopez-Alegria from the United States.
M. Pathy, aged 52, is the CEO and founder of the investment firm MAVRIK CORP. He is recognized in Montreal, the city where he resides, to support several causes as a philanthropist. Married and father of three children, Mark Pathy decided to leverage his participation in this mission to collaborate with the Canadian Space Agencies to conduct experiments in microgravity that are a priority for children’s and universities. 
As a Mission Specialist, he will be taking part in a total of 12 science research projects in partnership with six Canadian universities and their investigators, including clinician-researchers at The Montreal Children’s Hospital and Child Health Research at the Research Institute of the McGill University Health Centre and become the first private Astronaut to wear Astroskin on board the International Space Station. Pathy will be funding himself the research conducted in Space and contribute to generating results and potential applications on earth that would have taken more time to be realized under the current Canadian space program.
Going to space involves months of planning. Canadian Private Astronaut Mark Pathy has been busy training at NASA Johnson Space Center ahead of the launch.
Pathy and his crew already took part in training exercises and will now embark on seventeen weeks of training to get ready for the mission. We look forward to following him and the Ax-1 mission in the coming weeks and months.
Japanese Astronaut Aki Hoshide (JAXA) Wears the Astroskin Bio-Monitor in the International Space Station
Japanese Astronaut Aki Hoshide was the 5th astronaut to wear the Astroskin Bio-Monitor system aboard the International Space Station last week. Astronauts use the Astroskin in space since 2019 to participate in various research studies, including "Vascular Aging", a project lead by University of Waterloo researchers.
Many more astronauts are scheduled to use Astroskin in space. The system is available to all participating space agencies and research universities. The most recent Astroskin payload was launched with SpaceX's mission CRS-23 on August 29th, 2021.
Microgravity affects fluid movements in the body and heat transmission (in the absence of convection movement in microgravity). This triggers physiological phenomena impossible to monitor on the ground and tests our models of human physiology. The Astroskin Bio-Monitor system gives scientists a tool to observe these phenomena in space. It also prepares us to maintain crew health during long space missions beyond low earth orbit (LEO), to the Moon and Mars.
A Brief History of the Astroskin
Here's a list of space launches that carried Astroskin payloads:
- SpaceX CRS-16 (December 5th, 2018)
- Cygnus NG-11 (April 17th, 2019)
- SpaceX CRS-18 (July 25th, 2019)
- SpaceX CRS-19 (December 5th, 2019
- SpaceX CRS-20 (March 7th, 2020)
- Cygnus NG-14 (October 3rd, 2020)
- SpaceX CRS-21 (December 6th, 2020)
- SpaceX CRS-22 (June 3rd, 2021)
- SpaceX CRS-23 (August 29th, 2021)
The Astroskin Vital Signs Monitoring Platform is also used on Earth on industrial projects and scientific research.
Information about Astroskin missions aboard the ISS:
https://lsda.jsc.nasa.gov/Hardware/hardconfig/3065
https://directory.eoportal.org/web/eoportal/satellite-missions/i/iss-bio-monitor-analyzer
Astroskin First Flight with Virgin Galactic and Kellie Gerardi
Washington, DC, USA (June 3rd, 2021): Virgin Galactic has announced a new contract to fly International Institute of Astronautical Sciences (IIAS) researcher Kellie Gerardi on a test flight of the company’s spaceflight system, during which Kellie will conduct experiments and test new healthcare technologies (including the Astroskin Bio-Monitor) while she's in space.
(Credits: Greentag89, Wikipedia)
The purpose of the research mission is to demonstrate and advance novel scientific research benefits and applications that the spaceflight system provides for human-tended payloads.
The mission will also demonstrate the potential of conducting human research in suborbital flight, building on the research and knowledge gained from a number of Kellie’s reduced gravity flight campaigns performed here on Earth, including with the National Research Council of Canada (NRC) and the Canadian Space Agency (CSA).
Virgin Galactic will be able to provide new benefits to the space science research community in the form of repeatability, affordability and quality of the weightless environment which have historically been barriers for many wanting to conduct human spaceflight research.
During the spaceflight, following the shutdown of the rocket motor, Kellie will unbuckle from her seat and undertake the actions necessary to complete each experiment during several minutes of weightlessness. Virgin Galactic will provide training and preparation so that she is fully equipped to carry out her job as mission specialist on this flight and provide on-site pre-flight support for each of the payload experiments.
Working with IIAS, NRC and CSA, Kellie has already operated each payload in reduced gravity flights and will be bringing that unique payload specialist experience to the research mission. The payloads will include bio-monitoring instrumentation, including the Astroskin Bio-Monitor wearable sensors system, developed by Hexoskin with the support of the Canadian Space Agency, that will measure the biological effects of launch, weightlessness, re-entry, and landing on spaceflight participants.
The Astroskin Bio-Monitor has been in operation in the International Space Station since 2019 and is used by space agencies (CSA, NASA, ESA), to monitor astronauts' vital signs in orbit. The Astroskin is also used on Earth by researchers of 5 continents for clinical research applications.
“This historic flight will demonstrate the role private space companies can play to advance our knowledge of human physiology in space, to prepare for future missions to the Moon and beyond” said Pierre-Alexandre Fournier, CEO and co-founder of Hexoskin. “Many private space companies are planning to use the Astroskin system for astronaut training and during spaceflight, because it’s already in operation in the International Space Station.”
For more information about Hexoskin's involvement in this test flight or the Astroskin wearable vital signs sensor system, please contact us by email (contact@hexoskin.com) or by phone at 1-888-887-2044.
New Payload to Launch with SpaceX Mission CRS-22
If the weather permits, Hexoskin is set to launch its 8th Astroskin payload in collaboration with the Canadian Space Agency on June 3rd aboard another SpaceX rocket from the Kennedy Space Center in Florida.
SpaceX Mission CRS-22 is the second launch of phase 2 of SpaceX's Commercial Resupply Service (CRS) contract. This is the 6th time SpaceX transports Astroskin equipment to the International Space Station, the 2 other payloads have been launched by Northrop Grumman's Cygnus rockets.
Microgravity affects fluid movements in the body and heat transmission (in the absence of convection movement in microgravity). This triggers physiological phenomena impossible to monitor on the ground and tests our models of human physiology. The Astroskin Bio-Monitor system gives scientists a tool to observe these phenomena in space. It also prepares us to maintain crew health during long space missions beyond low earth orbit (LEO), to the Moon and Mars.
A Brief History of the Astroskin
Astronauts from space agencies (NASA, CSA, ESA) have used the Astroskin system aboard the International Space Station since January 2019.
Here's a list of space launches that carried Astroskin payloads:
- SpaceX CRS-16 (December 5th, 2018)
- Cygnus NG-11 (April 17th, 2019)
- SpaceX CRS-18 (July 25th, 2019)
- SpaceX CRS-19 (December 5th, 2019
- SpaceX CRS-20 (March 7th, 2020)
- Cygnus NG-14 (October 3rd, 2020)
- SpaceX CRS-21 (December 6th, 2020)
- SpaceX CRS-22 (June 3rd, 2021)
The Astroskin Vital Signs Monitoring Platform is also used on Earth on industrial projects and scientific research.
Information about Astroskin missions aboard the ISS:
https://lsda.jsc.nasa.gov/Hardware/hardconfig/3065https://directory.eoportal.org/web/eoportal/satellite-missions/i/iss-bio-monitor-analyzer
Hexoskin Talks Space Medicine at the Healthcare without Boundaries Colloquium
Biomedical researcher Héloïse Auger will talk about Hexoskin's work in space medicine, Astroskin wearable sensors, and artificial intelligence for automated diagnostics at the Healthcare without Boundaries Colloquium this week on June 1-2. Registration is available on Eventbrite: Healthcare without Boundaries Colloquium
Hexoskin has been collaborating with the Canadian Space Agency since 2011 on the development of medical technologies that can be used for human spaceflight. Devices that can record health data passively, like the Astroskin, create an opportunity to develop autonomous medical systems using clinical rules and artificial intelligence to support long-term space missions beyond low Earth orbit.
Astroskin Live Demo
Join us on March 24, 2021 for the Astroskin Live Demo
Hexoskin will provide a demonstration of the capabilities of the Astroskin, an advanced wearable technology designed to continuously monitor the five vital signs.
We will cover the following topics:
- Astroskin Vital Signs Monitoring Platform
- Demo of the Astroskin Apps & Dashboard
- Current & Future Applications
- Q&A
Register your place today!
